Literature DB >> 93550

Substance P infusion into substantia nigra of the rat: behavioural analysis and involvement of striatal dopamine.

A E Kelley, S D Iversen.   

Abstract

The purpose of the present study was to characterize the nature of the behavioural response to substance P (SP) infusion into the substantia nigra and to evaluate this response in 6-hydroxydopamine (6-OHDA) caudate lesioned rats. The effects of SP infusions (3 microgram in 1 microliter bilaterally) were assessed in an open field. Two groups of rats were used: one with 6-OHDA lesions in the caudate nucleus, and one with sham lesions. In sham rats, the first infusion produced a strong increase in sterotyped rearing and sniffing, with no concurrent enhancement of locomotion. With three subsequent infusions (made at interval of two days) the rearing response disappeared and a tendency to groom emerged. All SP-induced behavioural stimulation was blocked in the caudate-lesioned rats; an effect of the lesion itself was reduced rearing. These results suggest that the response to SP infusion is mediated through the nigro-striatal dopamine system. The behavioural profiles which emerge after SP infusion into the substantia nigra and ventral tegmental area are compared. In general, the behavioural studies of SP effects support the concept that the A9 and A10 dopamine systems can be behaviourally differentiated.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 93550     DOI: 10.1016/0014-2999(79)90216-4

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  7 in total

1.  Behavioral analysis of the effect of substance P injected into the ventral mesencephalon on investigatory and spontaneous motor behavior in the rat.

Authors:  A E Kelley; M Cador; L Stinus
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

2.  Striato-nigral dynorphin and substance P pathways in the rat. I. Biochemical and immunohistochemical studies.

Authors:  I Christensson-Nylander; M Herrera-Marschitz; W Staines; T Hökfelt; L Terenius; U Ungerstedt; C Cuello; W H Oertel; M Goldstein
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

3.  Motor effects following application of putative excitatory amino acid antagonists to the region of the mesencephalic dopamine cell bodies in the rat.

Authors:  D Dawbarn; C J Pycock
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1981-12       Impact factor: 3.000

4.  Tachykinin antagonists inhibit the morphine withdrawal response in guinea-pigs.

Authors:  P A Johnston; L A Chahl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-03       Impact factor: 3.000

5.  Acute changes in nigral substance P content induced by drugs acting on dopamine, muscarine and GABA receptors.

Authors:  K Koshiya; T Kato
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1983-11       Impact factor: 3.000

Review 6.  Neuropeptides in dopamine-containing regions of the brain.

Authors:  A Albanese; M C Altavista
Journal:  Ital J Neurol Sci       Date:  1984-12

7.  Responses of limbic and extrapyramidal substance P systems to nicotine treatment.

Authors:  Mario E Alburges; Paul S Frankel; Amanda J Hoonakker; Glen R Hanson
Journal:  Psychopharmacology (Berl)       Date:  2008-09-05       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.